World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 22 April 2013
Main ID:  NCT00125216
Date of registration: 27/07/2005
Primary sponsor: Department of Veterans Affairs
Public title: Evaluation of the Effects of Response Elaboration Training for Aphasia
Scientific title: Evaluation of the Effects of Response Elaboration Training for Aphasia
Date of first enrolment: December 2004
Target sample size: 47
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00125216
Study type:  Interventional
Study design:  Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment  
Countries of recruitment
United States
Contacts
Name:   Julie L. Wambaugh, PhD
Address: 
Telephone:
Email:
Affiliation:  VA Salt Lake City Health Care System, Salt Lake City
Key inclusion & exclusion criteria

Inclusion Criteria:

- Diagnosis of moderate to severe nonfluent or fluent aphasia

- Nonverbal intelligence within normal limits

- Auditory and visual acuity adequate for experimental tasks

- 6 months post-onset of single, focal brain injury (e.g., stroke)

Exclusion Criteria:

- Previous history of therapy with RET

- Diagnosed psychological disorder other than depression

- Neurological condition other than that which resulted in aphasia

- History of alcohol or substance abuse

- Non-native English speaker

- Premorbid history of speech/language disorder



Age minimum: 21 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Aphasia
Language Disorders
Speech Disorders
Intervention(s)
Behavioral: Response Elaboration Training
Primary Outcome(s)
verbal production of meaningful content words in connected speech [Time Frame: 3 and 6 weeks following completion of treatment]
Secondary Outcome(s)
Secondary ID(s)
C3719-R
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history